Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-81726-2, published online 26 January 2021

The original version of this Article contained an error in Figure 7, where 'P-EGFR 0 mg/kg' in panel B was a duplication of 'AREG 1 mg/kg' in panel A.

The original Figure 7 and accompanying legend appear below.

Figure 7
figure 7

SAMiRNA-AREG inhibited EGFR phosphorylation by downregulating AREG in UUO- or AD-induced renal fibrosis. (a,b) Representative images of AREG expression and EGFR phosphorylation revealed overexpression in the UUO- or AD-induced models of renal fibrosis, which was attenuated by SAMiRNA-AREG administration (1 mg/kg or 5 mg/kg). The AREG- and p-EGFR-positive areas were quantified. Scale bar, 100 μm. ***p < 0.001 compared to UUO or AD mice by ANOVA with the Newman-Keuls post-hoc test.

The original Article has been corrected.